Cardiopulmonary bypass is a technique that temporarily takes over the function of the heart and the lungs during a surgery, maintaining the blood circulation as well as the oxygen content of the body. Cardiopulmonary bypass is a form of extracorporeal circulation. A cardiopulmonary bypass circuit is designed to perform four major functions viz. circulation of blood, oxygenation and carbon dioxide elimination, systemic cooling and rewarming, and diversion of blood from the heart to provide a bloodless surgical field. Cardiopulmonary bypass systems mechanically circulate and oxygenate blood for the body while bypassing the heart and the lungs. The system uses a heart–lung machine to maintain perfusion to other body organs. The blood is cooled during cardiopulmonary bypass and returned to the body. Cardiopulmonary bypass pump is often referred to as heart–lung machine or simply, as pump. Extracorporeal circulation and cardiopulmonary bypass are synonymous terms denoting a method by which the blood that usually returns directly to the heart is temporarily drained from the superior and inferior vena cava.
Factors such as growing prevalence of chronic diseases such as cardiovascular and respiratory diseases, surging adoption of unhealthy lifestyle, rapid growth of population, increasing number of surgical procedures, and rising health care expenditure are key drivers for the cardiopulmonary bypass systems market. According to Lancet Global Surgery, about 30,537 procedures per 100,000 people are performed in an operation room in the U.S. Technological advancements, mergers and acquisitions, and growing health care awareness among people are other factors augmenting the cardiopulmonary bypass systems market. In 2015, Sorin Group and Cyberonics Inc. announced their merger, creating a new premier global medical technology company. The proposed transformational transaction would bring together global leaders in the fields of cardiac surgery and neuromodulators. On the other hand, strict regulations and adverse effects of bypass procedures are projected to hinder the cardiopulmonary bypass systems market in the near future.
The cardiopulmonary bypass systems market has been segmented based on product, application, end-user, and geography. In terms of product, the market has been classified into heart–lung machines, heat exchangers, oxygenators, autotransfusion systems, and accessories. In terms of application, the market has been classified into cardiovascular, respiratory, and hemodialysis & hemofiltration. In terms of end-user, the market has been segmented into hospitals, specialty clinics, dialysis centers, and ambulatory surgery centers.
Geographically, the global cardiopulmonary bypass systems market has been classified into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America dominates the global market, due to presence of large pool of patients, technological advancements, rise in research activities, and high health care expenditure. According to the American Heart Association, cardiovascular diseases (CVDs) has been listed as the primary cause of death in the U.S. The American Heart Association has funded more than US$ 4 Bn to research since 1949. Factors such as presence of key players (for example, Getinge AB and LivaNova PLC) and increasing research and development activities in the region make Europe the second-largest market for cardiopulmonary bypass systems. The market in the Asia Pacific region is expected to expand at a higher rate during the forecast period, due to presence of emerging players, rising prevalence of cardiovascular diseases, and increasing health care expenditure in the region. According to Medicouncil, around 17.5 million people are estimated to die of cardiovascular diseases every year in India, which is approximately 31% of all deaths worldwide.
Major players operating in the global cardiopulmonary bypass systems market are Medtronic Plc, Getinge AB, LivaNova PLC, Terumo Corporation, MicroPort Scientific Corporation, Xenios AG, Nipro Corporation, Eurosets Srl, OriGen Biomedical, and Thoratec Corporation.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.